Journal Article Summary
The article investigates the risks associated with using skeletal muscle relaxants (SMRs) alongside opioids, specifically hydrocodone, oxycodone, and tramadol. This topic is significant because the concurrent use of these medications is common, especially for managing painful musculoskeletal conditions. However, previous studies have indicated that combining these drugs may increase the risk of injuries and adverse events, prompting the need to understand how different SMRs affect injury rates when used with opioids.
The researchers conducted nine retrospective cohort studies using data from a US Medicaid population, focusing on individuals who were prescribed both an SMR and one of the three opioids. They analyzed the injury rates among various SMRs compared to methocarbamol, which is considered to have lower sedating effects. The study found that certain SMRs, like carisoprodol and tizanidine when used with oxycodone, and baclofen and cyclobenzaprine with tramadol, were associated with higher injury rates compared to methocarbamol. Conversely, metaxalone and tizanidine showed lower injury rates when used simultaneously with tramadol.
Despite its valuable findings, the study has limitations, including potential misclassification of drug exposure and the inability to adjust for SMR dosages. Additionally, the research could not account for unmeasured confounding factors, such as illicit drug use, which may influence injury risks. Patients and caregivers should discuss these findings with healthcare professionals, especially when considering the combination of opioids and SMRs, to ensure safe and effective pain management tailored to individual needs.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Chen Cheng, Hennessy Sean, Brensinger Colleen M., Miano Todd A., Bilker Warren B., Dublin Sascha, Chung Sophie P., Horn John R., et al.. Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants. Clinical pharmacology and therapeutics 2024. DOI: 10.1002/cpt.3248. PMID: 38482733. PMCID: PMC11180590.
Featured Pill Pals Product
Methocarbamol 500 mg Tablets --- Generic For Robaxin --- Granules
Methocarbamol 500 mg Tablets — Generic For Robaxin — Granules is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
